Kellner Capital’s AstraZeneca AZN Stock Holding History

Kellner Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-23,100	Closed	-$1.63M	–	47
2014 Q4	$1.63M	Buy	+23,100	New	+$1.65M	1.11%	23

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kellner Capital's AZN Position: Q1 2015 in Review

Kellner Capital sold out of AstraZeneca (AZN) in Q1 2015, closing a stake of 23,100 shares — an estimated $1.63M sold.

Kellner Capital first reported a position in AZN in Q4 2014 and held it in 1 quarter. The position peaked at $1.63M in Q4 2014. 386 funds tracked by Wall St. Rank hold AZN as of Q1 2015.

Kellner Capital reported no remaining AstraZeneca position as of Q1 2015 after selling out during the quarter.
Kellner Capital sold 23,100 AstraZeneca shares in Q1 2015, an estimated $1.63M.
Kellner Capital first reported a position in AstraZeneca in Q4 2014 and held it in 1 quarter.
Kellner Capital's AstraZeneca position peaked at $1.63M in Q4 2014.
386 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2015.

Based on Kellner Capital's 13F filing for Q1 2015, filed 4 May 2015.